Nobody's watching the post-quantum hardware mandate. $420M cash, $3.5 stock. $LAES
$LAES
AI SUMMARY — Lantheus Medical Technologies (LAES) is trading at $3.50 with $420M cash, positioning it as a potential post-quantum computing hardware play that few investors are monitoring. Key risks include the speculative nature of quantum-resistant technology adoption timelines, execution risks in scaling production, and potential dilution from financing needs.
| TICKER | LAES |
USER | u/LaoBanRouge |
| RATING |
BULLISH |
ENTRY |
$3.48
|
| POSITION |
2873 sh
SYN
|
BOOK VAL |
$9998.04 |
| CURRENT |
$3.23 |
P&L % |
-7.04%
|
| CURR VAL |
$9294.15 |
P&L $ |
-703.89
|